文献速递肿瘤 PET/CT

PET/CT显示18F-PSMA-1007在黄体摄取增高

Increased Uptake of 18F-PSMA-1007 in Corpus Luteum Demonstrated by PET/CT.
PubMed 文献 · Clin Nucl Med · 2022-01-01

两例女性患者因声门下区及支气管腺样囊性肿瘤随访行18F-PSMA-1007 PET/CT,局部复发及已知转移灶仅见有限示踪剂摄取,但两例均意外发现卵巢黄体处示踪剂高摄取。

要点

  • 18F-PSMA-1007 PET/CT随访腺样囊性肿瘤时,局部复发及转移灶摄取有限。
  • 两例女性患者均意外发现卵巢黄体处18F-PSMA-1007高摄取。
  • 卵巢黄体可表现为18F-PSMA-1007 PET/CT的意外高摄取部位。

核心结论

  • 两例女性腺样囊性肿瘤随访患者中,18F-PSMA-1007 PET/CT均意外发现卵巢黄体高摄取。

研究设计与样本

  • 两例女性患者分别因声门下区及支气管腺样囊性肿瘤随访行18F-PSMA-1007 PET/CT。

主要发现

  • 局部复发区域及已知转移区域仅见有限示踪剂摄取。
  • 两例女性患者卵巢黄体处均见意外高示踪剂摄取。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Two women were referred for an 18F-PSMA-1007 PET/CT in follow-up of an adenoid cystic tumor of the subglottic region and the bronchus, respectively. Only limited tracer uptake was seen in the region of local recurrence and in the region of known metastases. Unexpectedly, an incidental finding consisting of a high tracer uptake at a corpus luteum in the ovary was found in both women.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Geysen A, Goffin K, Van Weehaeghe D, et al. Increased Uptake of 18F-PSMA-1007 in Corpus Luteum Demonstrated by PET/CT. Clin Nucl Med. 2022. PMID: 35025782. doi:10.1097/RLU.0000000000004013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。